Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with ALS (also known as Lou Gehrig's disease) by a neurologist, at any confirmed level of certainty using standard diagnostic guidelines.
- You are already enrolled in a related research study called "Precision ALS."
- You are able to understand what taking part involves and are willing to give your consent for your information to be used in the study.
- You are willing to use a smartphone or tablet and download apps needed for the study.
- You are over 18 years old.
- You have a reliable home internet (broadband) connection and are willing to use it to share data for the study.
Who may not be able to join:
- You have been diagnosed with another neurological condition (other than ALS), active dementia, or a mental health condition that would make it difficult to follow the study's assessment schedule.
- You have another health condition that could put your safety at risk or prevent you from fully taking part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dara Meldrum, PhD, University of Dublin, Trinity College
Phone: +353 1 8964497
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Completion of 12-month follow up period; System Usability Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.